ACCP Journals

Results from this study support the need to create medication management programs to decrease exposure to potentially inappropriate prescribed medications. OPEN ACCESS: https://buff.ly/cAkeNnU

Incorporation of a collaborative, interprofessional chronic care management program into a single-center family medicine clinic proves to have clinical and financial benefits in a medically complex patient population with T2D. OPEN ACCESS: https://buff.ly/7Wl1VRo

The concurrent use of thiazide diuretics and SSRIs is associated with an increased risk of hyponatremia in older populations. OPEN ACCESS: https://buff.ly/7tEB6rg

The findings from this study suggest that clinical pharmacist management of T2DM does not further contribute to the disparities experienced by Hispanic patients, but rather, it can serve as a valuable resource in their care. https://lnkd.in/gMi5PtC2

This model holds promise for broader application in managing chronic diseases in underserved populations, highlighting the critical role of pharmacists in interdisciplinary health care teams. FREE TO READ: https://buff.ly/wLmfDCH

Within diabetes care, continuous glucose monitoring (CGM) is transforming how we monitor and manage patients with diabetes. FREE TO READ: https://buff.ly/My34X5F

The community pharmacy environment is currently challenging, and there are efforts to transform these practices to become more patient-centered. FREE TO READ: https://buff.ly/THRmAqB

Although GLP-1RAs are generally not associated with drug–drug interactions (DDIs) via drug metabolism or transporter pathways, their effects on reduced gastrointestinal (GI) motility could influence the pharmacokinetics of coadministered oral medications. OPEN ACCESS: https://buff.ly/HUnQXMD

A pharmacist-driven protocolized approach to the transition to SQ insulin post-operatively in cardiothoracic patients is both safe and efficacious. FREE TO READ https://buff.ly/619O7p3

Is there a significant change in potassium levels with sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy in people with type 2 diabetes (T2D)? https://buff.ly/OkQ4YrW